Omar H. Khalil

Omar H. Khalil is currently the Managing Director at Santé Ventures and holds several board positions, including at Geneos Therapeutics, Kestrel Therapeutics, Solu Therapeutics, and MycRx. They previously served as Vice President & General Manager at kaleo and Senior Director of Program Management at Baxter Healthcare Corporation. Omar's experience includes roles at McKinsey & Co. as a Business Analyst and as a Research Associate at the University of Michigan. They are pursuing a BSE and an MSE in Biomedical Engineering at the University of Michigan.